NEW YORK (GenomeWeb News) – Belgium’s AlgoNomics has entered into a research partnership with the Danish antibody company Genmab, the company announced today.
 
AlgoNomics plans to assist Genmab with detailed structural analysis of its fully human antibody molecules and antibody scaffolds, including Genmab’s new small, stable, modified antibody technology, UniBody.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.